Search / Trial NCT06223724

Status Telemetry for Cochlear Implantations

Launched by INSEL GRUPPE AG, UNIVERSITY HOSPITAL BERN · Jan 15, 2024

Trial Information

Current as of October 08, 2024

Recruiting

Keywords

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Informed Consent signed by the subject
  • * Subjects scheduled for CI surgery according to clinical routine
  • * Subjects who will receive a cochlear implant of the MED-EL portfolio (FLEX series arrays)
  • * No radiological contraindications
  • * Stated willingness to comply with all study procedures for the duration of the study
  • Exclusion Criteria:
  • * Lack of compliance with any inclusion criteria
  • * Subjects incapable of giving informed consent
  • * Age under 18 years
  • * Pregnancy

About Insel Gruppe Ag, University Hospital Bern

Insel Gruppe AG, the umbrella organization for the University Hospital Bern, is a leading healthcare provider in Switzerland, renowned for its commitment to advancing medical research and patient care. As a key player in clinical trials, Insel Gruppe AG integrates cutting-edge scientific inquiry with clinical excellence, facilitating innovative studies that span a wide range of medical disciplines. The institution prioritizes collaboration with academic partners and industry stakeholders to enhance the understanding of diseases and develop effective treatment options, ultimately aiming to improve patient outcomes and contribute to the global medical community.

Locations

Bern, , Switzerland

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0